{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:48:44Z","timestamp":1790502524158,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00393","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T07:57:01Z","timestamp":1559807821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial"],"prefix":"10.3389","volume":"10","author":[{"given":"Maximus","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Markulev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hok Pan","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam R.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Mossaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Schl\u00f6gelhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Smesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B.","family":"Hickie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor E.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Y. H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien H.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Riecher-R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd W.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison Ruth","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Paul","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13030418","article-title":"Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis","volume":"172","author":"Lin","year":"2015","journal-title":"Am J Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2324","article-title":"Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification","volume":"73","author":"Fusar-Poli","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414533012","article-title":"Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries","volume":"48","author":"Davis","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20144","article-title":"Biomarkers and clinical staging in psychiatry","volume":"13","author":"McGorry","year":"2014","journal-title":"World Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.1472","article-title":"Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk","volume":"69","author":"Fusar-Poli","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/wps.20526","article-title":"Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis","volume":"17","author":"Davies","year":"2018","journal-title":"World Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00187","article-title":"Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: a network meta-analysis","volume":"9","author":"Davies","year":"2018","journal-title":"Front Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.187","article-title":"Update on omega-3 polyunsaturated fatty acids in early-stage psychotic disorders","volume":"37","author":"Amminger","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1039856217698237","article-title":"Novel biotherapies are needed in youth mental health","volume":"25","author":"Amminger","year":"2017","journal-title":"Australas Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"Dyall","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"Van Meer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2009.01.004","article-title":"Comparative effects of DHA and EPA on cell function","volume":"122","author":"Gorj\u00e3o","year":"2009","journal-title":"Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prostaglandins.2012.01.005","article-title":"Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation","volume":"97","author":"Weylandt","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.08.014","article-title":"A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia","volume":"141","author":"Van Der Kemp","year":"2012","journal-title":"Schizophr Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.04.036","article-title":"Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls","volume":"228","author":"Rice","year":"2015","journal-title":"Psychiatry Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1220","DOI":"10.1038\/tp.2017.190","article-title":"Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study","volume":"7","author":"Berger","year":"2017","journal-title":"Transl Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx021.042","article-title":"23. omega-3 fatty acid versus placebo in a clinical high-risk sample from the North American Prodrome Longitudinal Studies (NAPLS) Consortium","volume":"43","author":"Cadenhead","year":"2017","journal-title":"Schizophr Bull"},{"key":"B21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","article-title":"Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the neurapro randomized clinical trial","volume":"74","author":"McGorry","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.2945","article-title":"\u03a9-3 polyunsaturated fatty acids to prevent psychosis: the importance of replication studies","volume":"74","author":"Kane","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151417","article-title":"Relationship between erythrocyte fatty acid composition and psychopathology in the vienna omega-3 study","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1192\/S0007125000297602","article-title":"Prediction of psychosis","volume":"172","author":"Yung","year":"1998","journal-title":"Br J Psychiatry Suppl"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12260","article-title":"NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders","volume":"11","author":"Markulev","year":"2015","journal-title":"Early Interv Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/lipd.12108","article-title":"A high-throughput method for the analysis of erythrocyte fatty acids and the omega-3 index","volume":"53","author":"Alqarni","year":"2018","journal-title":"Lipids"},{"key":"B27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.schres.2018.09.022","article-title":"Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: findings from the North American Prodrome Longitudinal Studies Consortium","volume":"209","author":"Cadenhead","year":"2018","journal-title":"Schizophr Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0361-9230(01)00551-2","article-title":"The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects","volume":"56","author":"Carver","year":"2001","journal-title":"Brain Res Bull"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.04.086","article-title":"Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults","volume":"421","author":"Conklin","year":"2007","journal-title":"Neurosci Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2009.28549","article-title":"Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study","volume":"91","author":"Mcnamara","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5498\/wjp.v5.i1.15","article-title":"Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: mechanisms and implications for psychopathology","volume":"5","author":"Mcnamara","year":"2015","journal-title":"World J Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.03.018","article-title":"A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression","volume":"68","author":"Lin","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.100","article-title":"Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis","volume":"17","author":"Bloch","year":"2012","journal-title":"Mol Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.25","article-title":"Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis","volume":"17","author":"Martins","year":"2012","journal-title":"Mol Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/1028415X.2017.1327685","article-title":"Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians","volume":"21","author":"Cribb","year":"2018","journal-title":"Nutr Neurosci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.clnme.2013.12.003","article-title":"Serum alpha-linolenic and linoleic acids are inversely associated with depressive symptoms in adults","volume":"9","author":"Kurotani","year":"2014","journal-title":"e-SPEN Journal"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0123","article-title":"Omega-3 fatty acid plasma levels before and after supplementation: correlations with mood and clinical outcomes in the omega-3 and therapy studies","volume":"27","author":"Arnold","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1017\/S204579601500116X","article-title":"Serum n-3 polyunsaturated fatty acids are inversely associated with longitudinal changes in depressive symptoms during pregnancy","volume":"26","author":"Pinto","year":"2017","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B40","unstructured":"USDA National Nutrient Database for Standard Reference, Legacy2018"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.01.014","article-title":"Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: a case-control study","volume":"171","author":"Hamazaki","year":"2016","journal-title":"Schizophr Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10545-018-0158-3","article-title":"Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders","volume":"41","author":"Mocking","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbi.2012.09.004","article-title":"Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial","volume":"28","author":"Kiecolt-Glaser","year":"2013","journal-title":"Brain Behav Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e3180313a45","article-title":"Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults","volume":"69","author":"Kiecolt-Glaser","year":"2007","journal-title":"Psychosom Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155099","article-title":"Six tissue transcriptomics reveals specific immune suppression in spleen by dietary polyunsaturated fatty acids","volume":"11","author":"Svahn","year":"2016","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.plefa.2014.05.007","article-title":"Beta-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels","volume":"92","author":"Chen","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs089","article-title":"Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis","volume":"39","author":"Peters","year":"2013","journal-title":"Schizophr Bull"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291709991711","article-title":"White-matter markers for psychosis in a prospective ultra-high-risk cohort","volume":"40","author":"Bloemen","year":"2010","journal-title":"Psychol Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.167","article-title":"Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals","volume":"17","author":"Amminger","year":"2012","journal-title":"Mol Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx089","article-title":"Plasma nervonic acid is a potential biomarker for major depressive disorder: a pilot study","volume":"21","author":"Kageyama","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010635","article-title":"Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study","volume":"5","author":"Assies","year":"2010","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2012.09.041","article-title":"Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis","volume":"207","author":"Hoen","year":"2013","journal-title":"Psychiatry Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0920-9964(02)00284-0","article-title":"Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia","volume":"62","author":"Arvindakshan","year":"2003","journal-title":"Schizophr Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2003.12.019","article-title":"Nutrition and schizophrenia: beyond omega-3 fatty acids","volume":"70","author":"Peet","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbv133","article-title":"Levels of red blood cell fatty acids in patients with psychosis, their unaffected siblings, and healthy controls","volume":"42","author":"Medema","year":"2016","journal-title":"Schizophr Bull"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.03.015","article-title":"Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder","volume":"126","author":"McNamara","year":"2010","journal-title":"J Affect Disord"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12282","article-title":"Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker","volume":"10","author":"McNamara","year":"2016","journal-title":"Early Interv Psychiatry"}],"updated-by":[{"DOI":"10.3389\/fpsyt.2020.00514","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000}}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:47:29Z","timestamp":1591966049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":59,"alternative-id":["10.3389\/fpsyt.2019.00393"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00393","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fpsyt.2020.00514","asserted-by":"object"}]},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"article-number":"393"}}